Literature DB >> 15891249

Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study.

Diane M Thiboutot1, Alan R Shalita, Paul S Yamauchi, Catherine Dawson, Stéphanie Arsonnaud, Sewon Kang.   

Abstract

BACKGROUND: Combination therapy with a topical retinoid and an antibiotic is recognized as a rational and effective approach for the treatment of acne vulgaris. Adapalene, a naphthoic acid derivative with anti-inflammatory and receptor-selective retinoid properties, is safe and well tolerated. While the combination of adapalene with oral or topical antibiotics has been shown to deliver a superior and faster response than an antibiotic alone, the clinical benefits of a combination of adapalene and doxycycline, the most frequently prescribed oral antibiotic for acne in the United States, have yet to be evaluated. OBJECTIVE AND METHODS: In a 12-week study, the efficacy and safety of the combination of adapalene gel 0.1% with doxycycline was compared with doxycycline alone for the treatment of severe acne. Subjects were randomized to receive doxycycline once daily in the morning and either adapalene or vehicle once daily in the evening.
RESULTS: At Week 12, the combination adapalene-doxycycline was significantly superior to doxycycline alone for change from baseline in total (p<0.001), inflammatory (p=0.02), and noninflammatory (p<0.001) lesions. Significant differences in total lesions were observed as early as Week 4 (p=0.04). Both treatments were well tolerated, and no serious adverse events were reported.
CONCLUSIONS: The study demonstrates that the combination of adapalene and an oral antibiotic provides a superior and faster benefit than antibiotic therapy alone and should be considered at the initiation of treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15891249     DOI: 10.1111/j.1540-9740.2005.04279.x

Source DB:  PubMed          Journal:  Skinmed        ISSN: 1540-9740


  8 in total

1.  The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome.

Authors:  Richard S Legro; Allen R Kunselman; Robert G Brzyski; Peter R Casson; Michael P Diamond; William D Schlaff; Gregory M Christman; Christos Coutifaris; Hugh S Taylor; Esther Eisenberg; Nanette Santoro; Heping Zhang
Journal:  Contemp Clin Trials       Date:  2012-01-13       Impact factor: 2.226

2.  A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies.

Authors:  Erica C Davis; Valerie D Callender
Journal:  J Clin Aesthet Dermatol       Date:  2010-04

Review 3.  [Drug therapy of acne].

Authors:  F R Ochsendorf; K Degitz
Journal:  Hautarzt       Date:  2008-07       Impact factor: 0.751

4.  Efficacy of mupirocin and rifampin used with standard treatment in the management of acne vulgaris.

Authors:  Farzin Khorvash; Fatemeh Abdi; Hessam H Kashani; Farahnaz Fatemi Naeini; Fariborz Khorvash
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

5.  A review of the use of adapalene for the treatment of acne vulgaris.

Authors:  Suleyman Piskin; Erol Uzunali
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

6.  Efficacy and tolerability of topical fixed combination of nadifloxacin 1% and adapalene 0.1% in the treatment of mild to moderate acne vulgaris in Indian patients: a multicenter, open-labelled, prospective study.

Authors:  Bela Jaswantlal Shah; Tharayil Kunneth Sumathy; Rachita Savalaram Dhurat; Raghunandan Govind Torsekar; Vishalakshi Viswanath; Jayesh Ishwardas Mukhi; Ganesh Kadhe; Pashmina Ahirrao
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494

7.  A Double-Blinded, Randomized, Vehicle-Controlled Study of the Efficacy of Moisturizer Containing Licochalcone A, Decanediol, L-Carnitine, and Salicylic Acid for Prevention of Acne Relapse in Asian Population.

Authors:  Kanokvalai Kulthanan; Suphattra Trakanwittayarak; Papapit Tuchinda; Leena Chularojanamontri; Pichaya Limphoka; Supenya Varothai
Journal:  Biomed Res Int       Date:  2020-10-16       Impact factor: 3.411

8.  Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite.

Authors:  Chandrashekhar Honrao; Xiaoyu Ma; Shashank Kulkarni; Vinit Joshi; Michael Malamas; Alexander Zvonok; JodiAnne Wood; David Strand; Jason J Guo; Alexandros Makriyannis
Journal:  Front Pharmacol       Date:  2020-09-30       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.